Member Info for Dibs61

The Salesforce deal also means that SNTY have effectively broke into the US CRM market without having to open an office over there - saving costs. My guess is that their sales people will travel to the states when required to present to potential customers rather than base themselves there.

Yep very illiquid Paisley. Mind you I can buy 5,000 @ 244 with a dummy buy trade. I just think this remains very much under the radar. A lot of PI's are only interested in and focus on penny shares. Some investors might not understand or even bother looking at the sector (if it's not Oil exploration!) There's a myriad of reasons why you don't see the interest (yet). Some investors WILL be looking but are unconvinced. Riddler was an example who briefly popped up here weeks ago to say beware AFTER the SP had already halved (which I found a little odd) and in the event that was actually the bottom! It's recovered since that cautionary (but uninformed) call. So, there you go, he's supposed to be one of the whizz kids on here.... My point being I just think people haven't got it yet. They haven't cottoned on. Interesting that COMS is different. The CEO there really blows their trumpet hard but the guys here are very understated and conservative. Just quietly get on with their business.

http://www.independent.ie/business/irish/shale-oil-and-gas-must-play-a-part-in-recovery-29418234.html

To quote Simon Cleaver back in March: "The Board believes that since January this year, the combined customer base of the additional integrated CRM platforms has increased CloudCall's addressable market from around 10,000 seats to over 1million in the UK and over 5 million seats worldwide." No longer looks like a fanciful claim - not that it ever did to me. The beauty of this offering is that we are not going cold to the market. We are piggy backing onto established creditable products with established customers - very big customers - with deep pockets. Wakey wakey Mr Market lol.

The more I'm considering this the bigger the deal becomes. Firstly, it is important to emphasise that a key part of todays announcement further to the integration partnership with salesforce is that it also involves a reseller agreement . This means that Salesforce will be marketing and promoting Synetys CloudCall product to both their existing and new customer bases. Synety are now expanding their sales team as they will likely have to follow up leads provided by salesforce and go in and present together. Salesforce is listed on the NYSE and has a MC of $25bn. Yes, I'll repeat that, US$25bn. This is big stuff people, big stuff.

It isn't hard to imagine widespread take up of this product amongst SNTY's integration partners customer bases. Why? Because it is not a 'nice to have' or 'wishlist' item. It will add value immediately and soon payback implementation cost. It will save businesses money and it will add value to their businesses by improving and enhancing their customer interaction.

Yep salesforce is a BIGGIE no question and the beauty is we have a ready made captive potential customer base. We also have our integration partner with a vested interest to help us sell our product. With straightforward and rapid implementation it's a quick win for all parties. I guess the question is how much is already priced into the SP because it's currently very difficult to pin down a valuation except to repeat what we have been saying - enormous growth potential. That'll do for now.

Completely overlooked by the market (naturally) but what a significant announcement. This is likely to have a big impact on revenue further down the road as Saleforce are one of the biggest CRM suppliers in the world and have an amazing customer base. When you see announcements like this slip totally under the radar it just re-emphasises that markets often do not work efficently but, sooner or later, the impact of this announcement will drag the market in!

Thanks for bumping up all this information Paisley. Hope you're right. It's clear now that they decided to avoid dilution (I was wrong in my conclusion there) and the so called 'Big Bang' expansion. They've stuck to their original business plan which may well prove to be the more prudent and successful course. They've also avoided taking a physical presence into the states which was a matter of some speculation - again probably a good decision at this stage at least. I'm expecting good growth in revenue. Whether that will feed to the bottom line at this early stage of their development I'm not so sure. There must be quite a lot of ramp up costs as they recruit larger numbers of employees and cut margins (free trials, low call costs) to encourage take up. That said, looking a bit longer term there's every reason to be extremely optimistic as quite simply they have a great offering to the market and very little direct competition in their niche space.

The SP should give us some indication of how things are progressing before the expected Sept trading update. Any further or continuing strength can be taken as a bullish sign of their success. I believe SC is quite conservative and not given to brash statements. I think that the number of seats they had in the first quarter was somewhere between 1,000-5,000 but we can assume that that number is growing steadily and could indeed be accelerating quite sharply. Just a reminder of what Simon Cleaver said back in March : "The Board believes that since January this year, the combined customer base of the additional integrated CRM platforms has increased CloudCall's addressable market from around 10,000 seats to over 1million in the UK and over 5 million seats worldwide. Further integrations are expected to be announced shortly. As we have now established a reasonable addressable market , and, whilst partner acquisition and integration will always be on-going, increased sales focus is starting to be directed to end user signup with a number of marketing initiatives, including a free 14 day trial, to be launched imminently. The early signs from this activity are certainly very encouraging, with the number of 'seats' sold this year increasing month on month. We are beginning to see that CloudCall's set of advanced, value-added telephone call services are capable of achieving good market share and are viewing the medium term with some confidence. At this time, it is still too early to accurately forecast the ultimate level of penetration CloudCall is likely to achieve, however, we hope be in a position to comment further in our interim statement for the 6 months to 30 June 2013, expected to be announced in September 2013. To handle this increase in volume, work is being carried out to strengthen both our customer facing operations and platform infrastructure. Since acquisition, Synety's infrastructure has been enhanced to provide a scalable, "fully redundant", high availability platform that has capacity for over 100,000 seats. The Board does not anticipate the need for further material capital expenditure in the UK in the medium term."

Interesting. Might not look like a lot but for SNTY thats a fair number of buy trades today. Barely any sells. Nice rise too. MM's must have been a bit liquid of stock as well because this normally moves quicker.

Pleasant surprise to see SNTY appear on the bottom LH corner of my page! Nice article Paisley. It's easy to see now how this functionality, so simple to use and implement, is an industry changer. Recording and managing call histories is critical to companies customer services teams and call centres. Now this has become much easier with CloudCall. (I should be on their sales team) Looking at the example below it can be seen that Sales Teams will also find CloudCall a very useful Add on to pursue and follow up leads using their CRM systems, so not only useful for existing customers but also potential/new ones as well.

Hi Paisley, this is another indication of what I was alluding to before about extending the product beyond the pure CRM space i.e..CloudCall being strictly an add on to a partners CRM system. It appears, in this case, as if a local company Communication Stem have built a connection between local NHS 111 AND the out of hours GP service together using CloudCallClick. I imagine that since Communication Stem is a company based in Bristol they had forged links with the local NHS and thats partly how SNTY got the deal. The question now is can SNTY use this as an effective customer reference and take this to other NHS trusts? We know that SNTY's current business model gets them income from a fixed monthly fee per user or 'seat' plus low cost calls so the question would be what are the potential seats they could win from this strategy. Whatever, I think it is an EXCELLENT move to target the public sector which is under enormous pressure to cut costs and if SNTY can demonstrate a clear cost saving we could be onto something.

Very interesting announcement this morning from SNTY regarding use of CloudCall Click in NHS Call Centre Bristol. Could this be the tip of a growing iceberg? ;-)

January - not good to have an emotional attachment to ANY company IMHO. This is not a love affair for me, it's strictly business and all about making profit. Certainly aware of the downside risk which exists in pretty much any AIM share does it not? So not sure what your point is.

Agreed. It's going to be a further wait to see how things develop. In essence it is these words from todays RNS which explain why the SP is @ 2.9: "These circumstances represent a material uncertainty that may cast significant doubt upon the Group and the Company's ability to continue as a going concern." IF they can get a farm in OR an acceptable restructuring of the debts then a great cloud will be lifted from this share! Big debt yes but P2 proven & probable of 131mmbo is not to be sniffed at in addition to a number of other possible exploration targets yet to be drilled. I also not that they have halted their drilling programme at Arbuzovskoye and intend to drill at least three further wells should the funding become available. Worth hanging onto IMHO.

Castaway - yep I would say the RNS was better than the apocalyptic scenario the SP had priced in. HOWEVER, they do need either a farm in (ideally) or a cash injection in the next six months or it could get very sticky. For me, with a relatively low average (3.8) it's worth the gamble because the rewards could still be high.

Yep there have been a number of very large trades gone through over the past couple of weeks and the SP has remained fairly static. I'm sure if most of those had been sells we wouldn't still be over 10p so I agree with you. I like that this a dependable profitable company (a rarity on AIM!) but what I'm really here for is their exposure to the healthcare sector (NHS). Also for their diagnostic capabilities but most of all their DNA sequencing technology which will become a central part of personalised treatment for patients I believe. I think this stock is overlooked and unrecognised for its long term potential.

Are you in yet mate? Nice solid day here.

Have to release results tomorrow and one would assume that they will provide a post year end update as well. Pretty disgusting that there has been no update whatsoever since March. A lot of bad news priced in, but is it all priced in? MM's massively dropped the price this morning on what appears to be little volume. Will we see delayed sells? Was it just a tactic to pick up shares? Who knows, but we will find out tomorrow or it's suspension!